Introduction to the Chronic Disease Cost Calculator

Introduction to the Chronic Disease Cost CalculatorPresented by Diane Orenstein, Ph.D., and Justin Trogdon, Ph.D.

April 1, 2010

Purpose of the CDCC (1 of 2) Estimate medical expenditures at the state level separately by

insured population for the following select chronic diseases: Arthritis Asthma Cancer Cardiovascular disease (CVD), including

Congestive heart failure (CHF) Coronary heart disease (CHD) Hypertension Stroke Other CVD (including other cerebrovascular disease)

Depression Diabetes

Estimates of medical expenditures are provided for the entire state population (all payers, including the uninsured) and separately for Medicaid, Medicare, and privately insured.

Purpose of the CDCC (2 of 2)

Estimate absenteeism costs for the above chronic diseases at the state level.

Allow the user to generate estimates of the costs of selected chronic diseases using customized inputs.

Project estimates of the medical costs of selected chronic diseases in the near future.

Accessing the CDCC Download Version 1 of the software at

http://www.cdc.gov/nccdphp/resources/calculator.htm

What’s New in Version 2 Estimates of the prevalence and costs of

Asthma, Arthritis and Depression Expanded estimates of the medical costs

from Medicaid only to Medicare, private insurance, and “all payers”

Estimates of absenteeism costs Projections of future medical costs (10

years) Charts

Intended Audience Chronic disease directors State Medicaid directors Other state and federal policy and

decision makers Federal agencies and others interested

in reviewing the burden of chronic disease across states and across the nation

Intended Use Provide estimates of medical expenditures and

absenteeism costs due to select chronic diseases at the state level. Many states do not have the resources

(financial and personnel) to do this themselves

Help policymakers quantify and understand the financial impact caused by chronic diseases

Inform decisions on investments in chronic disease prevention and disease management programs

DRAFT—Please do not cite

What the Calculator Does

Estimates for arthritis, asthma, cancer, cardiovascular disease (CHF, CHD, hypertension, stroke, and other CVD), depression, and diabetes at the state level: 1) prevalence, 2) medical costs by payer, and 3) absenteeism costs

Minimizes double-counting of Medicaid dollars going to multiple diseases

Creates sound estimates with no additional data required

Allows users to input their own data in place of default estimates

What the Calculator Does Not Do

Does not provide exact prevalence or medical and absenteeism costs of the chronic diseases for each state—only estimates

Not designed for comparisons across states

Does not include other costs of chronic disease, including productivity losses and reductions in the quality of life

Does not make policy or value judgments on spending for chronic disease

Next Steps Update source data (e.g., MEPS)

through 2007, the most recent year available

Expected release—Summer 2010

Investigators CDC Investigators

Diane Orenstein (DHDSP) Isaac Nwaise (DHDSP) Brett Miner (DHDSP) Nicole Blair (DHDSP) Florence Tangka (DCPC) Donatus Ekwueme (DCPC) Rui Li (DDT) Tursynbek Nurmagambetov (NCEH) Louise Murphy (DACH) Daniel Chapman (DACH)

RTI Investigators Susan Haber Eric Finkelstein Justin Trogdon

Other Collaborators

Agency for Healthcare Research and Quality (AHRQ)

National Association of Chronic Disease Directors (NACDD) Especially Chris Maylahn and John Robitscher

National Pharmaceutical Council (NPC) External Review Panel

Ken Thorpe (Emory) Steve Teutsch (Merck) Allison Rosen (U. of Michigan)